| Dr Jose I Almodovar - Laborde, MD | |
|
Carr. 2 Km 174.0, San German Medical Plaza Suite 207, San German, PR 00683-9340 | |
| (787) 892-3513 | |
| (787) 892-7422 |
| Full Name | Dr Jose I Almodovar - Laborde |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 31 Years |
| Location | Carr. 2 Km 174.0, San German, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508874876 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | 11632 (Puerto Rico) | Primary |
| Entity Name | Mayaguez Medical Center Dr Ramon Emeterio Betances Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013140383 PECOS PAC ID: 8527107341 Enrollment ID: O20101208000497 |
News Archive
The U.S. Food and Drug Administration (FDA) is alerting the public to a voluntary recall being conducted by Perrigo Company (Perrigo) of Allegan, Michigan for 383 lots of acetaminophen 500mg caplets manufactured and distributed under various store-brands as a result of small metal fragments found in a small number of these caplets.
Contrary to earlier studies, new research suggests that omega-3 fatty acids may not benefit thinking skills. The study is published in the September 25, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. Omega-3s are found in fatty fish such as salmon and in nuts.
Incisive Surgical, Inc. today announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for another key patent application, "Mechanical Method and Apparatus for Tissue Fastening." The allowed claims include subject matter covering the method of the INSORB Skin Closure technology and specific stapler features.
VIROPRO today provided updates on its business. Stockholders meeting was postponed because items to be voted upon by stockholders required production of the audited financial statements and these are not yet available.
Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced positive interim results from a randomized Phase 2 clinical trial evaluating the vascular disrupting agent (VDA) plinabulin (NPI-2358) in combination with standard chemotherapy (docetaxel) in patients with advanced non-small cell lung cancer (NSCLC).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jose I Almodovar - Laborde, MD Hc 3 Box 25716, San German Medical Paza, San German, PR 00683-9340 Ph: (787) 892-3513 | Dr Jose I Almodovar - Laborde, MD Carr. 2 Km 174.0, San German Medical Plaza Suite 207, San German, PR 00683-9340 Ph: (787) 892-3513 |
News Archive
The U.S. Food and Drug Administration (FDA) is alerting the public to a voluntary recall being conducted by Perrigo Company (Perrigo) of Allegan, Michigan for 383 lots of acetaminophen 500mg caplets manufactured and distributed under various store-brands as a result of small metal fragments found in a small number of these caplets.
Contrary to earlier studies, new research suggests that omega-3 fatty acids may not benefit thinking skills. The study is published in the September 25, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. Omega-3s are found in fatty fish such as salmon and in nuts.
Incisive Surgical, Inc. today announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for another key patent application, "Mechanical Method and Apparatus for Tissue Fastening." The allowed claims include subject matter covering the method of the INSORB Skin Closure technology and specific stapler features.
VIROPRO today provided updates on its business. Stockholders meeting was postponed because items to be voted upon by stockholders required production of the audited financial statements and these are not yet available.
Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced positive interim results from a randomized Phase 2 clinical trial evaluating the vascular disrupting agent (VDA) plinabulin (NPI-2358) in combination with standard chemotherapy (docetaxel) in patients with advanced non-small cell lung cancer (NSCLC).
› Verified 7 days ago